What is the CVSS score of CVE-2023-27170?

CVE-2023-27170 has a CVSS 3.1 base score of 7.5 (High). CVSS vector: CVSS:3.1/AV:N/AC:H/PR:L/UI:N/S:U/C:H/I:H/A:H. EPSS exploitation probability: 0.8%.

Is there a public PoC exploit available for CVE-2023-27170?

Yes, a public proof-of-concept exploit is available for CVE-2023-27170. Prioritise patching immediately. EPSS: 0.8%.

Write Back Manager CVE-2023-27170

HIGH

Path Traversal (CWE-22)

2023-10-26 cve@mitre.org

Path Traversal Write Back Manager

7.5

CVSS 3.1 · NVD

Severity by source

NVD PRIMARY

7.5 HIGH

AV:N/AC:H/PR:L/UI:N/S:U/C:H/I:H/A:H

Primary rating from NVD · only source for this CVE.

CVSS VectorNVD

CVSS:3.1/AV:N/AC:H/PR:L/UI:N/S:U/C:H/I:H/A:H

Attack Vector

Network

Attack Complexity

High

Privileges Required

Low

User Interaction

None

Scope

Unchanged

Confidentiality

High

Integrity

High

Availability

High

Lifecycle Timeline

CVE Published

Oct 26, 2023 - 23:15 nvd

HIGH 7.5

DescriptionNVD

Xpand IT Write-back manager v2.3.1 allows attackers to perform a directory traversal via modification of the siteName parameter.

AnalysisAI

Xpand IT Write-back manager v2.3.1 allows attackers to perform a directory traversal via modification of the siteName parameter. Rated high severity (CVSS 7.5), this vulnerability is remotely exploitable. Public exploit code available and no vendor patch available.

Technical ContextAI

This vulnerability is classified as Path Traversal (CWE-22), which allows attackers to access files and directories outside the intended path. Xpand IT Write-back manager v2.3.1 allows attackers to perform a directory traversal via modification of the siteName parameter. Affected products include: Xpand-It Write-Back Manager.

RemediationAI

No vendor patch is available at time of analysis. Monitor vendor advisories for updates. Validate and canonicalize file paths. Use chroot or sandboxing. Reject input containing path separators or '../' sequences.